← FDA DRUG APPROVALS

FDA ANDA · ANDA077616

SOTALOL HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA USA

APPLICATION
ANDA077616
TYPE
ANDA
ORIGINAL APPROVAL
2007-02-07
LATEST ACTION
2024-04-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 160MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 80MG · TABLET · ORAL
SOTALOL HYDROCHLORIDEPrescription
SOTALOL HYDROCHLORIDE 120MG · TABLET · ORAL

Approval history

2024-04-30Labeling · Supplement 5 · standardAP
2024-04-30Labeling · Supplement 8 · standardAP
2015-08-25Labeling · Supplement 4AP
2007-02-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →